Patent · US Active

Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1

US9481668B2 · kind B2 · utility

1Cited by

4References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Oliver Schadt · Rodenbach, DE
Christina Esdar · Darmstadt, DE
Carsten Schultz-Fademrecht · Pomezia, IT
Jan Eickhoff · Herdecke, DE

Key dates

Filing date	May 7, 2014
Grant date	Nov 1, 2016
Priority date	—
Expiry date	May 7, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The compound N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-5-ethyl-1 -(pyrimidin-5-yl)-1H-pyrazole-4-carboxamideand pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios,is an inhibitor of RON and can be employed, for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.